
COVID-19 overshadowed CRISPR’s advancements this year. The July issue of Nature Biotechnology keeps you up with the latest news and trends in genome editing, covering clinical testing, tools, patents, and more.
COVID-19 overshadowed CRISPR’s advancements this year. The July issue of Nature Biotechnology keeps you up with the latest news and trends in genome editing, covering clinical testing, tools, patents, and more.